Evaluation of a tetravalent dengue vaccine by serostatus and serotype

Lancet. 2020 May 2;395(10234):1402-1404. doi: 10.1016/S0140-6736(20)30603-6. Epub 2020 Mar 17.

Author

Annelies Wilder-Smith¹

Affiliation

¹ London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK; Heidelberg Institute of Public Health, University of Heidelberg, Heidelberg, Germany. Electronic address: annelies.wilder-smith@lshtm.ac.uk.

PMID: 32197106
DOI: 10.1016/S0140-6736(20)30603-6

No abstract available

Publication types

Comment

MeSH terms

Adolescent
Child
Child, Preschool
Dengue Vaccines*
Dengue Virus / immunology*
Dengue*
Humans
Serogroup

Substances

Dengue Vaccines